In children and teenagers, treatment with zonisamide was associated with a significant reduction in the number of monthly migraine days, particularly after at least 2 months of use, preliminary data show.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.